Support for CHMP Scientific Advice

September 22, 2020
  • Drug Development

Two global companies recently entrusted to BlueReg the management of a Committee for Medicinal Products for Human Use (CHMP) Scientific Advice procedure. Scientific Advice procedures not only give the Applicant the perfect opportunity to build an early, good, and trustworthy relationship with the Regulatory Authorities, but also greatly increases the chances of successfully bringing a product to market when the received advice is taken into consideration in the development program.

Register to download the Case study

    By sending this form, I agree that my personal data will be saved and processed according to data protection regulations and will be used only for commercial and marketing purposes only.

    Learn more

    BlueReg undertakes to comply with the regulations in force applicable to the processing of personal data and, in particular, Regulation (EU) 2016/679 of the European Parliament and of the Council of 27 April 2016 applicable as from 25 May 2018 (hereinafter, "the General Data Protection Regulations" or GPDR) and the national laws resulting therefrom.
    Any inquiries, correction or declaration of event related to personal data processed should be sent to: GDPR data request

    GDPR data request

    Thank you for your interest in BlueReg.

    The file will be sent to you by email.

    Download your Case study